Filing Flows › Johnson & Johnson (JNJ) › Capital expenditures
Johnson & Johnson (JNJ) capital expenditures by quarter
Johnson & Johnson's capital expenditures were $1.4B in Q3 2026 (third quarter 2026), +3% from Q2 2026. Over the last 7 quarters it ranged from $795M (Q1 2025) to $1.8B (Q4 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $1.4B | +3% | +18% |
| Q2 2026 | $1.3B | +26% | +27% |
| Q1 2026 | $1.0B | -43% | +32% |
| Q4 2025 | $1.8B | +59% | — |
| Q3 2025 | $1.2B | +11% | — |
| Q2 2025 | $1.0B | +31% | — |
| Q1 2025 | $795M | — | — |
Q3 2026 at a glance
Johnson & Johnson, Q3 2026: revenue $25.4B (+6% year over year), operating margin 0.1%, net earnings $210M, operating cash flow $7.7B. The chart follows the revenue to costs, profit and cash.
Questions
What is Johnson & Johnson's capital expenditures?
Johnson & Johnson's capital expenditures were $1.4B in Q3 2026 (third quarter 2026), +3% from Q2 2026.
How has Johnson & Johnson's capital expenditures changed?
Over the last 7 quarters it ranged from $795M (Q1 2025) to $1.8B (Q4 2025).